Expanding access to biotherapeutics in low-income and middle-income countries through public health non-exclusive voluntary intellectual property licensing: considerations, requirements, and opportunities
28 November 2022
The Lancet Global Health published a paper by Medicines Patent Pool co-authors on expanding access to biotherapeutics in low- and middle-income countries (LMICs) through public health non-exclusive voluntary intellectual property licensing.
The key elements identified as relevant to support access to affordable biosimilars in LMICs through licensing include:
- prioritising potential biotherapeutic targets according to their potential for public health impact
- supporting biosimilar product and clinical development
- facilitating biosimilars’ entry and use in LMICs
Co-authors include Sébastien Morin, Giulia Segafredo, Aditi Das, Meghmala Das, Nicola Loffredi, Amina Larbi, Elena Villanueva, Kim Mwamelo, Sandra Nobre, Manuele Piccolis and Esteban Burrone.